Cytokinetics Inc (CYTK)
60.58
+1.05
(+1.76%)
USD |
NASDAQ |
May 20, 16:00
60.58
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Total Long Term Debt (Quarterly): 618.13M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 618.13M |
December 31, 2023 | 617.45M |
September 30, 2023 | 609.02M |
June 30, 2023 | 609.78M |
March 31, 2023 | 610.62M |
December 31, 2022 | 610.58M |
September 30, 2022 | 608.53M |
June 30, 2022 | 197.02M |
March 31, 2022 | 195.68M |
December 31, 2021 | 142.84M |
September 30, 2021 | 140.96M |
June 30, 2021 | 139.14M |
March 31, 2021 | 137.39M |
December 31, 2020 | 135.71M |
September 30, 2020 | 134.02M |
June 30, 2020 | 132.37M |
March 31, 2020 | 130.80M |
December 31, 2019 | 129.26M |
September 30, 2019 | 44.76M |
June 30, 2019 | 44.47M |
March 31, 2019 | 42.59M |
December 31, 2018 | 42.41M |
September 30, 2018 | 41.90M |
June 30, 2018 | 32.36M |
March 31, 2018 | 31.95M |
Date | Value |
---|---|
December 31, 2017 | 31.78M |
September 30, 2017 | 30.30M |
June 30, 2017 | 30.16M |
March 31, 2017 | 30.02M |
December 31, 2016 | 29.88M |
September 30, 2016 | 29.74M |
June 30, 2016 | 29.60M |
March 31, 2016 | 29.47M |
December 31, 2015 | 14.64M |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.152M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
44.47M
Minimum
Jun 2019
618.13M
Maximum
Mar 2024
299.43M
Average
141.90M
Median
Total Long Term Debt (Quarterly) Benchmarks
Amgen Inc | 64.02B |
Johnson & Johnson | 33.63B |
Viking Therapeutics Inc | -- |
Eli Lilly and Co | 26.21B |
Madrigal Pharmaceuticals Inc | -- |